Concepedia

E Téllez Bernal

ET

Statistics

Publications

3

Citations

71

H-Index

3

Active since

1993

Affiliations

GlaxoSmithKline (United States)(Current)

E Téllez Bernal is an author at GlaxoSmithKline (United States) specializing in oncology, medicine, and high-dose chemotherapy.

Publications per year

1993–2022

3

Publications

3

Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy

Iris Lodewijk, Alejandra Bernardini, Cristian Suárez-Cabrera et al. · npj Precision Oncology · 2022 · 27 citations · Full text

Medicine, Immunology, Oncology +17

Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.

P. Wibault, Mohamed-el-amine Bensmaine, M Forni et al. · Journal of Clinical Oncology · 1996 · 26 citations

Medicine, Oncology, Radiation Oncology +16

Low Toxicity with Continuous Infusion of High-Dose Bleomycin in Poor Prognostic Testicular Cancer

Raquel Gerson, E Téllez Bernal, Marielisa León et al. · American Journal of Clinical Oncology · 1993 · 18 citations

Pharmacy, Oncology, Pharmacology +17

1–3 of 3